Filing Details

Accession Number:
0000932440-10-000071
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-01 13:00:00
Reporting Period:
2010-03-31
Filing Date:
2010-04-01
Accepted Time:
2010-04-01 15:23:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1043873 Novadel Pharma Inc NVDL Pharmaceutical Preparations (2834) 222407152
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033508 Jay Moorin C/o Proquest Investments
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1143319 Proquest Investments Ii Advisors Fund Lp
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1143544 Proquest Investments Ii Lp
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1225107 Proquest Associates Ii Llc
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1225149 Alain Schreiber C/o Proquest Investments
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1306133 Proquest Investments Iii, L.p.
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
1306134 Proquest Associates Iii Llc
90 Nassau Street, 5Th Floor
Princeton NJ 08542-4520
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-31 4,848,485 $0.17 34,353,138 No 4 P Indirect See
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrants to Purchase Common Stock Acquisiton 2010-03-31 2,424,243 $0.00 2,424,243 $0.25
Common Stock Series B Warrants to Purchase Common Stock Acquisiton 2010-03-31 1,616,162 $0.00 1,616,162 $0.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,424,243 2010-03-31 2015-03-31 No 4 P Indirect
1,616,162 2010-03-31 2010-09-30 No 4 P Indirect
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrants to Purchase Common Stock $0.19 2005-11-25 2010-05-26 1,394,871 1,394,871 Indirect
Common Stock Warrants to Purchase Common Stock $0.19 2006-10-12 2011-04-12 206,899 206,899 Indirect
Common Stock Warrants to Purchase Common Stock $0.19 2006-12-27 2011-12-27 384,766 384,766 Indirect
Common Stock Warrants to Purchase Common Stock $0.19 2008-12-01 2013-05-30 3,000,000 3,000,000 Indirect
Common Stock Warrants to Purchase Common Stock $0.19 2009-04-17 2013-10-17 6,446,809 6,446,809 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2010-05-26 1,394,871 1,394,871 Indirect
2011-04-12 206,899 206,899 Indirect
2011-12-27 384,766 384,766 Indirect
2013-05-30 3,000,000 3,000,000 Indirect
2013-10-17 6,446,809 6,446,809 Indirect
Footnotes
  1. Of such total shares: 23,417,138 are owned by ProQuest Investments III, L.P. ("Investments III"), of which ProQuest Associates III LLC ("Associates III") is the general partner; 9,530,152 are owned by ProQuest Investments II, L.P. ("Investments II"), of which ProQuest Associates II LLC ("Associates II") is the general partner; and 143,101 are owned by ProQuest Investments II Advisors Fund, L.P. ("Advisors"), of which Associates II is the general partner. Jay Moorin and Alain Schreiber are managing members of Associates III and Associates II. All of such new shares were acquired by Associates II. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  2. Of such warrants: 1,107,078 are owned by Investments III; 281,030 are owned by Investments II; and 6,763 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  3. Of such warrants: 164,210 are owned by Investments III; 41,684 are owned by Investments II; and 1,005 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  4. Of such warrants: 305,380 are owned by Investments III; 77,520 are owned by Investments II; and 1,866 are owned by Advisors. Each of the reporting persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  5. Of such warrants: 2,381,030 are owned by Investments III; 604,419 are owned by Investments II; and 14,551 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  6. Of such warrants: 5,116,683 are owned by Investments III; 1,298,858 are owned by Investments II; and 31,268 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  7. Such warrants are owned by Investments II. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  8. On March 31, 2010, Investments II acquired 4,848,485 shares of Common Stock, Series A Warrants to purchase 2,424,243 shares of Common Stock and Series B Warrants to purchase 1,616,162 shares of Common Stock, all for an aggregate price of $800,000.03.